CPRT vs NRXPW · P/E 19, rev $3.51B vs rev $242.0K
Copart Inc (CPRT) versus NRx Pharmaceuticals Inc (NRXPW) — a side-by-side from cached financials, not a winner call.
Copart Inc (CPRT) is a specialty business services company listed on US.
NRx Pharmaceuticals Inc (NRXPW) common stock listed on NASDAQ.
Latest reported CPRT revenue for 2026-04-30 was $3.51B. Net income was $1.16B. Revenue was up 54.3% from 2026-01-31 to 2026-04-30. CPRT currently screens at market cap $28.66B and trailing P/E 19.2.
Latest reported NRXPW revenue for 2025-09-30 was $242.0K. Net income was -$5.9M. NRXPW currently screens at market cap $714.6M.
CPRT currently screens at market cap $28.66B and trailing P/E 19.2. NRXPW currently screens at market cap $714.6M.
Not investment advice. Open the CPRT and NRXPW stock pages for the full models.
Not investment advice.